Effects of Nothrombel on Thrombin-Induced Formation of Thrombocyte-Leukocyte Complexes

[1]  A. Zarbock,et al.  Platelets in leucocyte recruitment and function. , 2015, Cardiovascular research.

[2]  Wei Wang,et al.  Platelet-Leukocyte Interaction in Atherosclerosis and Atherothrombosis: What We Have Learnt From Human Studies and Animal Models , 2014 .

[3]  L. Boon,et al.  Abstract 178: Platelet Cd40 Exacerbates Atherosclerosis by Transcellular Activation of Endothelial Cells and Leukocytes , 2013, Arteriosclerosis, Thrombosis, and Vascular Biology.

[4]  E. D. Candia,et al.  Mechanisms of platelet activation by thrombin: A short history , 2012 .

[5]  V. Evangelista,et al.  ATVB in Focus Platelets Unplugged: Focus on Platelet Biology , 2010 .

[6]  C. Balduini,et al.  Thrombin induces platelet activation in the absence of functional protease activated receptors 1 and 4 and glycoprotein Ib-IX-V. , 2010, Cellular signalling.

[7]  D. Jackson,et al.  Platelets: pleiotropic roles in atherogenesis and atherothrombosis. , 2010, The international journal of biochemistry & cell biology.

[8]  D. Newby,et al.  Flow cytometric analysis of circulating platelet-monocyte aggregates in whole blood: Methodological considerations , 2007, Thrombosis and Haemostasis.

[9]  K. Ley,et al.  Platelet-neutrophil-interactions: linking hemostasis and inflammation. , 2007, Blood reviews.

[10]  W. Daniel,et al.  Course of Platelet Activation and Platelet-Leukocyte Interaction in Cerebrovascular Ischemia , 2006, Stroke.

[11]  P. Théroux,et al.  Clopidogrel inhibits platelet-leukocyte interactions and thrombin receptor agonist peptide-induced platelet activation in patients with an acute coronary syndrome. , 2004, Journal of the American College of Cardiology.

[12]  P. Sidhu,et al.  Platelet degranulation and monocyte–platelet complex formation are increased in the acute and convalescent phases after ischaemic stroke or transient ischaemic attack , 2004, British journal of haematology.

[13]  F. Adam,et al.  Thrombin interaction with platelet membrane glycoprotein Ib alpha. , 2003, Trends in molecular medicine.

[14]  P. Conley,et al.  P2Y12 regulates platelet adhesion/activation, thrombus growth, and thrombus stability in injured arteries. , 2003, The Journal of clinical investigation.

[15]  J. Vermylen,et al.  Inhibition of von Willebrand factor-GPIb/IX/V interactions as a strategy to prevent arterial thrombosis , 2003, Expert review of cardiovascular therapy.

[16]  S. Harder,et al.  Clopidogrel but not aspirin reduces P‐selectin expression and formation of platelet‐leukocyte aggregates in patients with atherosclerotic vascular disease * , 2003, Clinical pharmacology and therapeutics.

[17]  J. Loscalzo,et al.  Platelet-monocyte aggregates: bridging thrombosis and inflammation. , 2002, Circulation.

[18]  S. Harder,et al.  Clopidogrel, but not abciximab, reduces platelet leukocyte conjugates and P‐selectin expression in a human ex vivo in vitro model , 2002, Clinical pharmacology and therapeutics.

[19]  V. Schini-Kerth,et al.  Close relationship between the platelet activation marker CD62 and the granular release of platelet-derived growth factor. , 2002, The Journal of pharmacology and experimental therapeutics.

[20]  D. Isenberg,et al.  Increased circulating platelet–leucocyte complexes and platelet activation in patients with antiphospholipid syndrome, systemic lupus erythematosus and rheumatoid arthritis , 2001, British journal of haematology.

[21]  M. Furman,et al.  Circulating Monocyte-Platelet Aggregates Are a More Sensitive Marker of In Vivo Platelet Activation Than Platelet Surface P-Selectin: Studies in Baboons, Human Coronary Intervention, and Human Acute Myocardial Infarction , 2001, Circulation.

[22]  P. Hjemdahl,et al.  Platelet-Leukocyte Cross Talk in Whole Blood , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[23]  P. Théroux,et al.  Evidence of platelet activation during treatment with a GPIIb/IIIa antagonist in patients presenting with acute coronary syndromes. , 2000, Journal of the American College of Cardiology.

[24]  S. Shattil.  Signaling Through Platelet Integrin αIIbβ3: Inside-out, Outside-in, and Sideways , 1999, Thrombosis and Haemostasis.

[25]  P. Théroux,et al.  Modulation of Platelet-neutrophil Interaction with Pharmacological Inhibition of Fibrinogen Binding to Platelet GPIIb/IIIa Receptor , 1999, Thrombosis and Haemostasis.

[26]  C. Bode,et al.  Induction of Fibrinogen Binding and Platelet Aggregation as a Potential Intrinsic Property of Various Glycoprotein IIb/IIIa (IIbβ3) Inhibitors , 1998 .

[27]  F. Neumann,et al.  Induction of cytokine expression in leukocytes by binding of thrombin-stimulated platelets. , 1997, Circulation.

[28]  C. Cerletti,et al.  Platelet/polymorphonuclear leukocyte interaction in dynamic conditions: evidence of adhesion cascade and cross talk between P-selectin and the beta 2 integrin CD11b/CD18. , 1996, Blood.

[29]  T. Springer,et al.  Neutrophil rolling, arrest, and transmigration across activated, surface-adherent platelets via sequential action of P-selectin and the beta 2-integrin CD11b/CD18. , 1996, Blood.

[30]  C. Smith,et al.  Leukocyte activation with platelet adhesion after coronary angioplasty: a mechanism for recurrent disease? , 1995, Journal of the American College of Cardiology.

[31]  P. Patrignani,et al.  Role of platelets in inflammation and cancer: novel therapeutic strategies. , 2014, Basic & clinical pharmacology & toxicology.

[32]  E. De Candia.  Mechanisms of platelet activation by thrombin: a short history. , 2012, Thrombosis research.

[33]  K. Clemetson,et al.  CHAPTER 6 – Platelet Receptors , 2007 .

[34]  K. Nogami,et al.  A critical role for thrombin in platelet aggregation under high shear stress. , 2004, Thrombosis research.